December 5, 2024

Dosing of the first patient in the POTAMI-61 Phase II Study of RVU120 for the Treatment of Patients with Myelofibrosis (MF)

Year

2024

Assets in this page

Download assets

  • pdf file

    Current Report ESPI 37/2024

    Download